Dr Mauro Ferrari
Scientific Advisory Board
Dr. Ferrari serves as President and CEO of Houston Methodist Research Institute, where he holds the Ernest Cockrell Jr. Presidential Distinguished Chair. He is also the director of the Institute of Academic Medicine and executive vice president of Houston Methodist, and is president of The Alliance for NanoHealth in Houston. Dr. Ferrari is an academic-entrepreneur, with several companies that originated from his laboratory. He currently serves on the Board of Directors for two companies: Nanomedical Systems of Austin TX and NASDAQ-traded Arrowhead Research Corporation (NASDAQ:ARWR). He is also a director, co-founder and scientific advisor for Leonardo Biosystems of Houston TX. Dr. Ferrari served as special expert on nanotechnology at the National Cancer Institute in 2003-2005, providing leadership into the formulation, refinement, and approval of the NCI’s Alliance for Nanotechnology in Cancer, currently the world’s largest program in medical nanotechnology. Dr. Mauro Ferrari is a founder of biomedical nano/micro-technology, especially in their applications to drug delivery, cell transplantation, implantable bioreactors, and other innovative therapeutic modalities. In these fields, he has published more than 200 peer-reviewed journal articles and six books. He is the inventor of more than 30 issued patents, with about thirty more pending in the US and internationally.
Dr. Ramesh Babu Padamati
Prof. Werner Blau
Prof. John J. Boland
Prof Conor Buckley
Prof. J.M.D. Coey
Prof Paula Colavita
Prof. Jonathan Coleman
Prof. Graham Cross
Prof. John Donegan
Prof. Georg S. Duesberg
Prof Garry Duffy
Prof James Gleeson
Prof. Yurii Gun’ko
Prof. Anne Marie Healy
Prof David Hoey
Prof. Justin D. Holmes
Prof Paul Hurley
Prof Nathan Jackson
Prof. Daniel Kelly
Dr. Ed Lavelle
Dr Rocco Lupoi
Prof. Mike Lyons
Dr. Aidan McDonald
Dr. Parvaneh Mokarian-Tabari
Prof. Mick Morris
Dr. Bruce Murphy
Prof. Valeria Nicolosi
Prof. Fergal O’Brien
Prof Kevin O’Connor
We have vacancies for a number of fully funded PhD positions across AMBER for enrolment in 2018. Studentships must have started by Sept/Oct 2018. To apply please review the projects listed below. Submit your CV, a cover letter explaining your interest in the programme and a maximum of 3 project selections that are of interest to you to firstname.lastname@example.org. Not all applications will be funded.
Friday 29th June 2018
SFI Industry Fellowship
The SFI Industry Fellowship Programme aims to enhance industry-academia collaborations, and to stimulate excellence through the funding of collaborative industry-academia research projects. This is realised via secondment of academic researchers in industry, or of industry researchers in academia.
If funded, the AMBER centre places researchers, on-site with collaborating companies for 1 year full time or 2 years part time. Alternately it hosts industry researchers on-site. Some applicants transition to full time roles in industry partners, subsequent to completion of the project. Other fellows have leveraged the secondment for:  preparation of large scale successfully funded H2020 funding applications;  publication of high impact academic publications;  pathfinding/seeding new collaborative research projects;  the development of new intellectual property.
To date AMBER has placed candidates across Ireland, Europe and the US addressing challenges in materials research for applications ranging across Bioengineering, Energy, ICT, and Medical Devices.
The next call deadline is Nov 26th - http://www.sfi.ie/funding/funding-calls/sfi-industry-fellowship-programme/. Typically there are 2 calls per annum. Companies or researchers interested in prospective applications can contact email@example.com for further information/informal discussions.
PhD, PostDocs in Biomaterial Scaffold Development
2 Postdoc and 2 PhD positions are available with Dr Cathal Kearney in RCSI arising from his ERC Horizon 2020 Starter Grant funded in the area of biomaterial scaffold development for diabetic foot ulcers. There are several parallel arms to the project that will look at aspects of scaffold design, on-demand drug delivery, nucleic acid delivery and induced pluripotent stem cells.
Postdoc – iPSCs and Scaffold - https://my.corehr.com/pls/coreportal_rcsip/erq_jobspec_details_form.jobspec?p_id=013127
Postdoc – biomaterials - https://my.corehr.com/pls/coreportal_rcsip/erq_jobspec_details_form.jobspec?p_id=013126
PhD – iPSCs and Scaffold - https://my.corehr.com/pls/coreportal_rcsip/erq_jobspec_details_form.jobspec?p_id=013125
PhD – On Demand Delivery - https://my.corehr.com/pls/coreportal_rcsip/erq_jobspec_details_form.jobspec?p_id=013145
Open Call for EDGE Scholarship Applications
EDGE is led by Trinity College Dublin on behalf of 10 Irish academic institutions of excellence. In our 2nd call we expect to award up to 45 Fellowships, each 24-months duration, who will relocate to Ireland to join expert supervisors in the ICT (networks, date and materials) field. Career progression is a primary aim of MSCA schemes, and we will provide comprehensive training and development to our Fellows to support their growth as independent research professionals. Researchers currently residing outside of Ireland, with a PhD or equivalent status, can apply by submitting a research proposal before the Call deadline on 1st November 2017.
Before beginning the application process, applicants should:
1. review the eligibility criteria and other information on our website - http://www.edge-research.eu
2. contact a prospective supervisor from those listed on the programme website to gain their support
- Future Networks & Communications
- Advanced Materials & Bioengineering
- Digital Content & Media Technologies
Full topic list: http://edge-research.eu/fellowships/research-themes/
Contact: Richard Twohig, EDGE Programme Manager: firstname.lastname@example.org
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 713567.